Managements of sleep bruxism in adult: A systematic review.
Managements of sleep bruxism in adult: A systematic review.
复制标题
DOI：
10.1016/j.jdsr.2022.02.004
复制
发表时间：
2022-11
期刊：
影响因子：
--
通讯作者：
Nishiyama A
中科院分区：
文献类型：
--
作者：
Minakuchi H;Fujisawa M;Abe Y;Iida T;Oki K;Okura K;Tanabe N;Nishiyama A
本系统综述旨在更新成人睡眠磨牙症（SB）的管理，使用多导睡眠图（PSG）和/或肌电图（EMG）诊断。治疗方法包括口腔矫治器治疗（OAT）与稳定夹板，认知行为治疗（CBT），生物反馈治疗（BFT）和药物治疗。在MEDLINE、科克伦图书馆和Web of Science上进行了全面检索，检索截止日期为2021年10月1日。参考清单搜索和手工搜索也由外部组织进行。每种疗法的两名评审员独立进行文章选择、数据提取和偏倚风险评估。评审员通过讨论解决了关于文章分类的任何分歧。最后，每种疗法分别选择了11、3、14和22篇文章。结果表明，OAT倾向于减少SB事件的数量，尽管与其他类型的夹板相比没有显著差异，CBT的潜在益处没有得到很好的支持，BFT、雷贝拉唑、氯硝西泮、可乐定和A型肉毒杆菌毒素注射剂显示特定SB参数显著降低，尽管报告了一些副作用。因此，需要更严格的随机大样本长期随访临床试验来阐明SB管理的有效性和安全性。
This systematic review aimed to update the management of sleep bruxism (SB) in adults, as diagnosed using polysomnography (PSG) and/or electromyography (EMG). Management methods covered were oral appliance therapy (OAT) with stabilization splints, cognitive-behavioral therapy (CBT), biofeedback therapy (BFT), and pharmacological therapy. A comprehensive search was conducted on MEDLINE, Cochrane Library, and Web of Science up to October 1st, 2021. Reference list searches and hand searches were also performed by an external organization. Two reviewers for each therapy independently performed article selection, data extraction, and risk of bias assessment. The reviewers resolved any disagreements concerning the assortment of the articles by discussion. Finally, 11, 3, 14, and 22 articles were selected for each therapy. The results suggested that OAT tended to reduce the number of SB events, although there was no significant difference compared to other types of splints, that the potential benefits of CBT were not well supported, and that BFT, rabeprazole, clonazepam, clonidine, and botulinum toxin type A injection showed significant reductions in specific SB parameters, although several side effects were reported. It can be concluded that more methodologically rigorous randomized large-sample long-term follow-up clinical trials are needed to clarify the efficacy and safety of management for SB.
登录
查看更多内容
影响因子：
7.2
作者：
Guyatt, Gordon H.;Oxman, Andrew D.;Schuenemann, Holger J.
通讯作者：
Schuenemann, Holger J.
影响因子：
2.6
作者：
Beddis, H.;Pemberton, M.;Davies, S.
通讯作者：
Davies, S.
影响因子：
3.1
作者：
FUNCH D P;GALE E N
通讯作者：
GALE E N
影响因子：
7.2
作者：
Guyatt, Gordon H.;Oxman, Andrew D.;Schuenemann, Holger J.
通讯作者：
Schuenemann, Holger J.
影响因子：
5.6
作者：
Huynh, Nelly;Lavigne, Gilles J.;de Champlain, Jacques
通讯作者：
de Champlain, Jacques